Accessibility navigation


Diheteroarylmethyl substituted titanocenes: a novel class of possible anti-cancer drugs

Pampillon, C., Sweeney, N.J., Strohfeldt, K. and Tacke, M. (2006) Diheteroarylmethyl substituted titanocenes: a novel class of possible anti-cancer drugs. Inorganica Chimica Acta, 359 (12). pp. 3969-3975. ISSN 0020-1693

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1016/j.ica.2006.05.021

Abstract/Summary

From the reaction of tert-butyl lithium or n-butyl lithium with N-methylpyrrole (1a), furan (1b) or 2-bromo-thiophen (1c), 2-N-methylpyrrolyl lithium (2a), 2-furyl lithium (2b) or 2-thiophenyl lithium (2c), respectively, was obtained. When reacted with 6-(2-N-methylpyrrolyl) fulvene (3a), 6-(2-furyl) fulvene (3b) or 6-(2-thiophenyl) fulvene (3c), the corresponding lithiated intermediates were formed (4a-c). Titanocenes (5a-c) were obtained through transmetallation with titanium tetrachloride. When these titanocenes were tested against pig kidney epithelial (LLC-PK) cells, inhibitory concentrations (IC50) of 32 mu M, 140 mu M, and 240 mu M, respectively, were observed. These values represent improved cytotoxicity against LLC-PK, compared to their ansa-analogues. (c) 2006 Elsevier B.V. All rights reserved.

Item Type:Article
Refereed:Yes
Divisions:Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy
ID Code:13661
Uncontrolled Keywords:anti-cancer drug, cis-platin, titanocene, fulvene, carbolithiation, LLC-PK, tert-butyl lithium , TITANIUM DICHLORIDE, ORGANIC-CHEMISTRY, ANSA-TITANOCENES, FULVENES, COMPLEXES, DERIVATIVES, METALLOCENES, CISPLATIN, AGENTS, TRIAL

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation